Additionally, cardiac troponin I levels are substantially increased in patients with severe COVID-19 compared with patients with a mild illness, potentially representing a biomarker to predict the deterioration of the clinical condition of patients with COVID-19 [86]. The gene discussed is TNNI3; the disease is COVID-19.